SFA for Medical Devices

Medical device field sales is among the most demanding commercial environments in any industry. Reps must have deep technical product knowledge. The accounts are complex institutions with multiple decision-making layers. Sales cycles run from months to years. And compliance documentation requirements - serial number tracking, installation records, regulatory reporting - are not optional extras but legal and commercial obligations.

SFA for medical devices is not a simplified version of pharma SFA. While there are structural similarities, the account complexity, in-theatre support requirements, and device lifecycle management demands make medical devices a distinct category that requires purpose-built workflows.

How Medical Devices Differs from Pharma

In pharma, the primary commercial relationship is with the individual prescriber. A doctor is a discrete target who can be called on regularly, and the rep’s job is to influence prescribing habits through detailing, clinical data, and samples. The sale is indirect - the doctor prescribes, the pharmacy dispenses.

In medical devices:

Accounts are institutions, not individuals. A hospital is the account, with multiple stakeholders whose alignment is required before a purchase decision is made.
Sales cycles are longer and non-linear. A device evaluation can involve clinical trials, committee reviews, procurement processes, and budget cycles spanning multiple years.
The rep is present at the point of use. In many device categories, reps support procedures in the operating theatre or clinical setting - a fundamentally different relationship with the customer than any other field sales category.
Post-sale engagement is substantial. Installation, training, service, and outcome follow-up are part of the commercial relationship in ways that simply do not apply to pharmaceutical products.

An SFA system built on a pharma template - optimising for individual call planning and sample management - will fail to capture the account complexity and device lifecycle requirements that define medical device field sales.

The Call Universe: Multi-Stakeholder Account Management

A hospital account involves multiple stakeholder categories, each with different priorities, different information needs, and different levels of influence over the purchase decision.

Stakeholder	Role in Decision	Primary Concerns
Surgeon / Specialist	Clinical champion or blocker	Device performance, outcomes, ease of use
Department Head	Clinical authority, internal advocate	Clinical outcomes, department reputation
Biomedical Engineer	Technical evaluator	Device specifications, maintenance, compatibility
Procurement / Materials Management	Commercial negotiator	Price, contract terms, vendor performance
Nursing / Clinical Staff	Day-to-day users	Ease of use, training, support responsiveness
Hospital Administrator	Budget authority	Cost per case, total cost of ownership

SFA for medical devices must handle multi-contact account management as a native feature - not as an afterthought. Each contact should have individual interaction histories, but all contacts should be linked to the account, and account-level progress should aggregate across all stakeholder interactions.

A rep who has met three times with a surgeon but has never engaged procurement is not managing the account - they are managing one relationship in a multi-relationship sale. SFA should make this gap visible.

Hospital Account Management

The hospital is the primary unit of analysis in medical device SFA, not the individual contact. Account management requires tracking:

Account profile: Hospital type (public/private/academic), bed count, relevant clinical departments, current device usage by category, competitive device presence.
Stakeholder map: Who are the key contacts, what are their roles, and what is the current relationship status with each?
Account status: Where is this account in the sales cycle? Active evaluation? Under contract with a competitor? In tender process? Budget cycle timing?
Revenue history and potential: What has been purchased historically? What is the estimated addressable spend per year across relevant categories?
Open issues: Any outstanding service calls, complaints, or unresolved clinical concerns that could affect the relationship.

Account reviews - regular manager-led assessments of the most important accounts - should be driven by SFA data. A manager reviewing a key hospital account should be able to see the complete stakeholder engagement history, the current pipeline status, and any open issues in a single view.

Device Demonstration and Trial Management

Device demonstrations and clinical evaluations are the primary conversion mechanism in medical devices. A surgeon who has used a device in a controlled trial, seen the clinical outcomes, and formed a preference based on personal experience is the most powerful advocate a company can have.

Trial management in SFA should cover:

Loaner unit tracking: Which units are placed for trial? At which account? With which surgeon? What is the agreed trial period?
Trial setup confirmation: Has the device been installed, calibrated, and staff trained prior to the trial commencing?
Outcome recording: Post-trial, what was the clinical outcome? What was the surgeon’s feedback? Were there any complications or concerns?
Trial-to-purchase conversion: Did the trial convert to a purchase order? If not, what was the reason?
Loaner unit return: Was the loaner unit returned? In what condition? This feeds into asset management and prevents loaner units from disappearing into accounts indefinitely.

Field sales research in medical devices consistently finds that structured trial management - with clear outcome recording and follow-up protocols - delivers materially higher conversion rates than informal demo processes managed via rep notes and emails. The discipline of the follow-up is as important as the trial itself.

In-Theatre Support

For surgical devices - implants, instruments, energy devices, robotics-assisted systems - the rep is often present in the operating theatre to support device use. This is a distinctive feature of medical device sales with significant compliance and relationship implications.

SFA should log in-theatre support events as a distinct interaction type, linked to the account and the surgeon:

Procedure date and type
Device(s) used and serial/lot numbers
Surgeon and clinical team present
Any issues or observations
Follow-up actions

In-theatre support is also a data source for post-market surveillance. If reps are logging device performance observations during procedures, this creates a structured feed into regulatory reporting obligations - far more reliable than relying on reps to separately file adverse event reports.

Compliance and Device Documentation

Medical device companies operate under regulatory frameworks that require traceability of every device from manufacture through installation and use. SFA is the field-level documentation system for this traceability.

Key compliance documentation requirements include:

Serial and lot number tracking: Every device placed, trialled, or installed must be logged with its unique identifier.
Installation records: For capital equipment and complex devices, installation date, location within the facility, and biomedical engineer sign-off should be recorded.
Service history: Maintenance visits, calibration records, and fault reports should be linked to the device record.
Regulatory reporting: Adverse events or device malfunctions observed in the field must be reported through a defined process. SFA should provide the workflow for field-level incident reporting.

Gaps in this documentation are not administrative failures - they are regulatory exposure. In the event of a device recall or adverse event investigation, incomplete serial number tracking at the account level creates significant legal and operational problems.

Tender Management

Government hospitals and large institutional networks procure medical devices through formal tender processes. Tenders represent a substantial portion of medical device revenue in most markets, and they operate on entirely different commercial logic than direct account sales.

SFA should support tender tracking as a distinct pipeline type:

Tender identification: Which tenders are open? What are the submission deadlines and evaluation criteria?
Product specifications: Are the tender specifications written in a way that favours the company’s device, or do specifications advantage a competitor?
Internal coordination: Tender responses typically require input from commercial, clinical, regulatory, and finance teams. SFA tracks the status and assigns owner responsibilities.
Submission and outcome: Was the tender submitted on time? What was the outcome? If lost, what was the reason?

Tender win rate - the percentage of submitted tenders that convert to contract awards - is a critical KPI for companies with significant institutional business. Tracking it systematically reveals patterns: categories where the company wins or loses consistently, geographies where pricing is uncompetitive, or specification writing where competitor relationships are influencing tender design.

KPIs for Medical Device SFA

KPI	What It Measures
Account coverage rate	% of target hospital accounts with at least one substantive interaction in the period
Stakeholder engagement breadth	Average number of distinct stakeholder roles engaged per key account
Demo conversion rate	% of device demonstrations that progress to trial or purchase
Trial-to-purchase conversion rate	% of clinical trials that convert to a purchase order
Tender win rate	% of submitted tenders that result in contract awards
In-theatre support compliance	% of in-theatre support events logged with required device and procedure data
Compliance documentation completeness	% of placed/installed devices with complete serial number, installation, and service records
Loaner unit cycle time	Average days from loaner placement to return or conversion to purchase

Getting SFA Right in Medical Devices

The common failure mode in medical device SFA implementation is configuring the system around individual rep activity metrics - calls made, contacts visited, samples delivered - rather than around account progress and pipeline advancement.

An account that has had 15 rep visits but remains at the same stage in the sales cycle is not a success story. It is a warning sign. SFA in medical devices should make account progression - movement toward clinical trial, trial completion, procurement engagement, tender submission, contract award - the primary metric, with activity metrics as supporting context rather than primary indicators.

The second failure mode is neglecting post-sale account management. In medical devices, the sale of a capital device or implant system is not the end of the commercial relationship - it is the beginning. Installation success, clinical staff confidence, outcome quality, and service responsiveness all determine whether the account renews, expands, or defects to a competitor at contract renewal. SFA that tracks only pre-sale activity misses half the commercial relationship.